1. Home
  2. MDIA vs ELUT Comparison

MDIA vs ELUT Comparison

Compare MDIA & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mediaco Holding Inc.

MDIA

Mediaco Holding Inc.

N/A

Current Price

$1.04

Market Cap

50.0M

ML Signal

N/A

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$0.90

Market Cap

41.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDIA
ELUT
Founded
2019
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.0M
41.9M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
MDIA
ELUT
Price
$1.04
$0.90
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
37.4K
58.7K
Earning Date
05-19-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
146.77
EPS
N/A
N/A
Revenue
$133,336,000.00
$12,293,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.83
P/E Ratio
N/A
N/A
Revenue Growth
39.52
N/A
52 Week Low
$0.54
$0.50
52 Week High
$1.64
$2.50

Technical Indicators

Market Signals
Indicator
MDIA
ELUT
Relative Strength Index (RSI) 54.95 44.57
Support Level $0.57 $0.88
Resistance Level $1.64 $1.18
Average True Range (ATR) 0.07 0.06
MACD -0.00 0.00
Stochastic Oscillator 58.11 36.43

Price Performance

Historical Comparison
MDIA
ELUT

About MDIA Mediaco Holding Inc.

MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Share on Social Networks: